Sterkem Pharma Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 26-06-2024
- Paid Up Capital ₹ 0.20 M
as on 26-06-2024
- Company Age 22 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.10 M
as on 26-06-2024
- Revenue 23.48%
(FY 2022)
- Profit -24.85%
(FY 2022)
- Ebitda 25.02%
(FY 2022)
- Net Worth 51.29%
(FY 2022)
- Total Assets 6.93%
(FY 2022)
About Sterkem Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹1.10 M.
Ajit Desai and Heena Patel serve as directors at the Company.
- CIN/LLPIN
U51909MH2002PTC135324
- Company No.
135324
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Mar 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sterkem Pharma Private Limited offer?
Sterkem Pharma Private Limited offers a wide range of products and services, including Antibiotic Tablets & Capsules, Azithromycin Tablets, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs.
Who are the key members and board of directors at Sterkem Pharma?
Board Members(2)
Financial Performance and Corporate Structure Insights of Sterkem Pharma.
Sterkem Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.48% increase. The company also saw a substantial fall in profitability, with a 24.85% decrease in profit. The company's net worth Soared by an impressive increase of 51.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sterkem Pharma?
In 2018, Sterkem Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
E M Pharmaceuticals Private Limited
Active
32 years 5 months Ajit Desai and Heena Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 13 Nov 2023 | ₹1.10 M | Open |
How Many Employees Work at Sterkem Pharma?
Sterkem Pharma has a workforce of 119 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Mar 19, 2013, Sterkem Pharma has raised a total of ₹ 65 K, with the most recent deal valued at ₹ 65 K. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
